DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)Most-boughtAI cap-ex
RXRX
RECURSION PHARMACEUTICALS IN
364 institutions still hold RECURSION PHARMACEUTICALS IN as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 75629V104·Biological Products, (No Diagnostic Substances)·364 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
364 institutions reported RXRX in Q1 2026. BlackRock, Inc. leads at 14.3% of the visible book. +40 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 19
344 more holders available. Log in →